A delay prior to mitotic entry triggers caspase 8-dependent cell death in p53-deficient Hela and HCT-116 cells

References

• Mistry SJ, Atweh GF. Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer. Mol Cancer Ther 2006; 5:3248-57; PMID:17172428; http://dx.doi.org/10.1158/1535-7163.MCT-06-0227
   PubMed Web of Science ®Google Scholar
• Belletti B, Baldassarre G. Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 2011; 15:1249-66; PMID:21978024; http://dx.doi.org/10.1517/14728222.2011.620951
   PubMed Web of Science ®Google Scholar
• Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002; 14:18-24; PMID:11792540; http://dx.doi.org/10.1016/S0955-0674(01)00289-7
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Wang Y, Gao P, Lin F, Liu L, Yu B, Ren JH, Zhao H, Wang R. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells. Cancer Biol Ther 2006; 5:1457-61; PMID:17012855; http://dx.doi.org/10.4161/cbt.5.11.3272
   PubMed Web of Science ®Google Scholar
• Wang R, Dong K, Lin F, Wang X, Gao P, Wei SH, Cheng SY, Zhang HZ. Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression. Mol Med 2007; 13:567-75; PMID:17873971; http://dx.doi.org/10.2119/2007-00046.Wang
   PubMed Web of Science ®Google Scholar
• Wang X, Ren JH, Lin F, Wei JX, Long M, Yan L, Zhang HZ. Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway. Cancer Biol Ther 2010; 10:632-43; PMID:20657188; http://dx.doi.org/10.4161/cbt.10.6.12654
   PubMed Web of Science ®Google Scholar
• Wang F, Wang LX, Li SL, Li K, He W, Liu HT, Fan QX. Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. J Surg Oncol 2011; 103:704-15; PMID:21360534; http://dx.doi.org/10.1002/jso.21870
   PubMed Web of Science ®Google Scholar
• Miceli C, Tejada A, Castaneda A, Mistry SJ. Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer. Cancer Gene Ther 2013; 20:298-307; PMID:23618950; http://dx.doi.org/10.1038/cgt.2013.21
   PubMed Web of Science ®Google Scholar
• Alli E, Bash-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002; 62:6864-9; PMID:12460900
   PubMed Web of Science ®Google Scholar
• Alli E, Yang JM, Hait WN. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 2007; 26:1003-12; PMID:16909102; http://dx.doi.org/10.1038/sj.onc.1209864
   PubMed Web of Science ®Google Scholar
• Carney BK, Cassimeris L. Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53. Cancer Biol Ther 2010; 9:699-709; PMID:20200495; http://dx.doi.org/10.4161/cbt.9.9.11430
   PubMed Web of Science ®Google Scholar
• Carney BK, Caruso Silva V, Cassimeris L. The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53. Cytoskeleton (Hoboken) 2012; 69:278-89; PMID:22407961; http://dx.doi.org/10.1002/cm.21024
   PubMed Web of Science ®Google Scholar
• Silva VC, Cassimeris L. Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1. Mol Biol Cell 2013; 24:3819-31; http://dx.doi.org/10.1091/mbc.E13-02-0108
   PubMed Web of Science ®Google Scholar
• Larsson N, Marklund U, Gradin HM, Brattsand G, Gullberg M. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 1997; 17:5530-9; PMID:9271428
   PubMed Web of Science ®Google Scholar
• Holmfeldt P, Segerman B, Howell B, Morabito J. Cassimeris L, Gullberg M. The catastrophe-promoting activity of ectopic Op18/stathmin is required for disruption of mitotic spindles but not for interphase microtubules. Mol Biol Cell 2001; 12:73-83; PMID:11160824; http://dx.doi.org/10.1091/mbc.12.1.73
   PubMed Web of Science ®Google Scholar
• Harley ME, Allan LA, Sanderson HS, Clarke PR. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 2010; 29:2407-20; PMID:20526282; http://dx.doi.org/10.1038/emboj.2010.112
   PubMed Web of Science ®Google Scholar
• Wang P, Lindsay J, Owens TW, Mularczyk EJ, Warwood S, Foster F, Streuli CH, Brennan K, Gilmore AP. Phosphorylation of the proapoptotic BH3-only protein Bid primes mitochondria for apoptosis during mitotic arrest. Cell Rep 2014; 7:661-71; PMID:24767991; http://dx.doi.org/10.1016/j.celrep.2014.03.050
   PubMed Web of Science ®Google Scholar
• Kreis NN, Louwen F, Yuan J. Less understood issues: p21Cip1 in mitosis and its therapeutic potential. Oncogene 2014;1-10.
   Web of Science ®Google Scholar
• Alli E, Yang JM, Ford JM, Hait WN. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol 2007; 71:1233-40; PMID:17272681; http://dx.doi.org/10.1124/mol.106.029702
   PubMed Web of Science ®Google Scholar
• Hirai H, Iwasawa Y, Okada M, Arai T, Nishibata T, Kobayashi M, Kimura T, Kaneko N, Ohtani J, Yamanaka K, et al. Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol Cancer Ther 2009; 8:2992-3000; PMID:19887545; http://dx.doi.org/10.1158/1535-7163.MCT-09-0463
   PubMed Web of Science ®Google Scholar
• Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, Heimbrook DC, Chen L. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci U S A 2006; 103:10660-5; PMID:16818887; http://dx.doi.org/10.1073/pnas.0600447103
   PubMed Web of Science ®Google Scholar
• Van Horn RD, Chu S, Fan L, Yin T, Du J, Beckmann R, Mader M, Zhu G, Toth J, Blanchard K, Ye XS. Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells. J Biol Chem 2010; 285, 21849-57; PMID:20444701; http://dx.doi.org/10.1074/jbc.M110.141010
   PubMed Web of Science ®Google Scholar
• Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008; 14:111-22; PMID:18656424; http://dx.doi.org/10.1016/j.ccr.2008.07.002
   PubMed Web of Science ®Google Scholar
• Orth JD, Tang Y, Shi J, Loy CT, Amendt C, Wilm C, Zenke FT, Mitchison TJ. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol Cancer Ther 2008; 7:3480-9; PMID:18974392; http://dx.doi.org/10.1158/1535-7163.MCT-08-0684
   PubMed Web of Science ®Google Scholar
• McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events. Cell Cycle 2014; 13:1400-12; PMID:24626186; http://dx.doi.org/10.4161/cc.28401
   PubMed Web of Science ®Google Scholar
• Fenech, M. The in vitro micronucleus technique. Mutation Res 2012; 455:81-95; http://dx.doi.org/10.1016/S0027-5107(00)00065-8
   Web of Science ®Google Scholar
• DeLuca J G. Kinetochore - microtubule dynamics and attachment stability. Methods Cell Biol 2010; 97:53-79; PMID:20719265; http://dx.doi.org/10.1016/S0091-679X(10)97004-0
   PubMed Web of Science ®Google Scholar
• Kubuota S, Fukumoto Y, Ishibashi K, Soeda S, Kubota S, Yuki R, Nakayama Y, Aoyama K, Yamauchi N, Yamaguchi N. Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage. J Biol Chem 2014; 289:5730-45; PMID:24421316; http://dx.doi.org/10.1074/jbc.M113.546655
   PubMed Web of Science ®Google Scholar
• Safa AR. c-FLIP, a master anti-apoptotic regulator. Exp Oncol 2012; 34:176-84; PMID:23070002
   PubMedGoogle Scholar
• Galligan L, Longley DB, McEwan M, Wilson TR, McLaughlin K, Johnston PG. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 2005; 4:2026-36; PMID:16373718; http://dx.doi.org/10.1158/1535-7163.MCT-05-0262
   PubMed Web of Science ®Google Scholar
• Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T, Takata Y, Kagawa S, Roth JA, Tschopp J, et al. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 2001; 20:5225-31; PMID:11526513; http://dx.doi.org/10.1038/sj.onc.1204673
   PubMed Web of Science ®Google Scholar
• Koivusalo R, Krausz E, Helenius H, Hietanen S. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Mol Pharmacol 2005; 68:372-82; PMID:15908516
   PubMed Web of Science ®Google Scholar
• Bartke T, Siegmund D, Peters N, Reichwein M, Henkler F, Scheurich P, Wajant H. p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene 2001; 20:571-80; PMID:11313989; http://dx.doi.org/10.1038/sj.onc.1204124
   PubMed Web of Science ®Google Scholar
• Zhou XD, Yu JP, Chen HX, Yu HG, Luo HS. Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer. WJG 2005; 11:2482-5; PMID:15832422; http://dx.doi.org/10.3748/wjg.v11.i16.2482
   PubMed Web of Science ®Google Scholar
• Day TW, Huang S, Safa AR. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells. Biochem Pharmacol 2008; 76:1694-704; PMID:18840411; http://dx.doi.org/10.1016/j.bcp.2008.09.007
   PubMed Web of Science ®Google Scholar
• Ewald F, Ueffing N, Brockmann L, Hader C, Telieps T, Schuster M, Schulz WA, Schmitz I. The role of c-FLIP splice variants in urothelial tumours. Cell Death Dis 2011; 2:e245; PMID:22190004; http://dx.doi.org/10.1038/cddis.2011.131
   PubMed Web of Science ®Google Scholar
• von Haefen C, Wendt J, Semini G, Sifringer M, Belka C, Radetzki S, Reutter W, Daniel PT, Danker K. Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. Oncogene 2002; 16:636-51
   Google Scholar
• Wieder T, Essman F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dorken B, Daniel PT. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 2001; 97:1378-87; PMID:11222383; http://dx.doi.org/10.1182/blood.V97.5.1378
   PubMed Web of Science ®Google Scholar
• Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K, et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43:432-48; PMID:21737329; http://dx.doi.org/10.1016/j.molcel.2011.06.006
   PubMed Web of Science ®Google Scholar
• Wilson TR, McLaughlin KM, McEwan M, Sakai H, Rogers KM, Redmond KM, Johnston PG, Longley DB. c-FLIP: a key regulator of colorectal cancer cell death. Cancer Res 2007; 67:5754-62; PMID:17575142; http://dx.doi.org/10.1158/0008-5472.CAN-06-3585
   PubMed Web of Science ®Google Scholar
• Matthess Y, Raab M, Sanhaji M, Lavrik IN, Strebhardt K. Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity. Mol Cell Biol 2010; 30:5726-40; http://dx.doi.org/10.1128/MCB.00731-10
   PubMed Web of Science ®Google Scholar
• Tu S, McStay GP, Boucher L-M, Mak T, Beere HM, Green DR. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 2006; 8:72-7; PMID:16362053; http://dx.doi.org/10.1038/ncb1340
   PubMed Web of Science ®Google Scholar
• Abedini MR, Muller EJ, Brun J, Bergeron B, Gray DA, Tsang BK. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Res 2008; 68:4511-7; PMID:18559494; http://dx.doi.org/10.1158/0008-5472.CAN-08-0673
   PubMed Web of Science ®Google Scholar
• Byrne FL, Yang L, Phillips PA, Hansford LM, Fletcher JI, Ormandy CJ, McCarroll JA, Kavallaris M. RNAi-mediated stathmin suppression reduces lung metastasis in a orthotopic neuroblastoma mouse model. Oncogene 2014; 33:882-90; PMID:23396365; http://dx.doi.org/10.1038/onc.2013.11
   PubMed Web of Science ®Google Scholar
• Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274:1541-8; PMID:9880531; http://dx.doi.org/10.1074/jbc.274.3.1541
   PubMed Web of Science ®Google Scholar
• Piehl M, Cassimeris L. Organization and dynamics of growing microtubule plus ends during early mitosis. Mol Biol Cell 2003; 14:916-25; PMID:12631713; http://dx.doi.org/10.1091/mbc.E02-09-0607
   PubMed Web of Science ®Google Scholar
• Grinshtein N, Datti A, Fujitani M, Uehling D, Prakesch M, Isaac M, Irwin MS, Wrana JL, Al-Awar R, Kaplan DR. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells. Cancer Res 2011; 71:1385-95; PMID:21303981; http://dx.doi.org/10.1158/0008-5472.CAN-10-2484
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang Z, Zhang H, Roth M, Bhatia R, Chen WY. Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model. Carcinogenesis 2012; 33:285-93; PMID:22116466; http://dx.doi.org/10.1093/carcin/bgr278
   PubMed Web of Science ®Google Scholar
• Ma HT, Tsang YH, Marxer M, Poon RY. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol Cell Biol 2009; 29:6500-14; PMID:19822658; http://dx.doi.org/10.1128/MCB.00669-09
   PubMed Web of Science ®Google Scholar